News and Events

Keep up-to-date on recent events, webinars and releases from ArcherDX.



Dec
5
2016

ArcherDX launches Immune Repertoire Sequencing Assays at ASH 2016

ArcherDX, the leader in NGS-based fusion assays, today announced the release of the Archer® Immunoverse™ immune repertoire sequencing assays. ArcherDX plans to reveal Immunoverse at the 58th American Society of Hematology Annual Meeting, which starts this weekend in San Diego, CA.


Nov
29
2016

Meet us at ASH 2016

Join us for the 2016 The American Society of Hematology (ASH) in San Diego, CA. By combining revolutionary AMP™ chemistry with an easy workflow and intuitive software, Archer is unleashing the power of translational NGS to enable mutation detection.


Nov
17
2016

ArcherDx Focuses on CDx and IVD Development Based on Patented Target Capture Tech

ArcherDx has been developing new products for cancer research and other applications over the past year and has established additional partnerships, including for companion diagnostic and in vitro diagnostic development. Last week, the company and its customers presented several posters at the American Molecular Pathology annual meeting on research involving many new assays. In addition, the firm was recently granted a US patent for its core technology, which enables open-ended capture of target sequences from a single primer for next-gen sequencing analysis.


Nov
14
2016

Anchored Multiplex PCR patent is issued to inventors at Massachusetts General Hospital

ArcherDX, the leader in next-generation sequencing (NGS)-based gene fusion detection products, announced today the issuance of the first patent for Anchored Multiplex PCR (AMP™), the technology that forms the foundation of the company’s products.


Oct
20
2016

Meet us at AMP 2016

Join us at the 2016 Association of Molecular Pathology Annual Meeting in Charlotte, North Carolina.


Oct
12
2016

ArcherDX at the Companion Diagnostics Symposium 2016

Join us at the 2016 Companion Diagnostics Symposium in Edison, NJ this November. By combining revolutionary AMP™ chemistry with an easy workflow and intuitive software, Archer® is unleashing the power of translational NGS to enable mutation detection.


Oct
5
2016

Validation of the Archer® FusionPlex® Solid Tumor Panel in the JAX Cancer Treatment Profile™

This webinar outlines the clinical validation of the incorporation of the Archer® FusionPlex® Solid Tumor Panel (AFPSTP) into the JAX Cancer Treatment Profile™ (JAX-CTP) test system


Sep
27
2016

ArcherDX at the 2016 ESMO Congress

Join us at the ESMO Congress in Copenhagen, Denmark on 7-11 October, 2016. Combining revolutionary AMP™ chemistry with an easy workflow and intuitive software, Archer® unleashes the power of translational NGS to enable mutation detection.


Sep
15
2016

Clinical Tumor Sequencing: Applications and considerations for targeted sequencing using Anchored Multiplex PCR

This webinar will review multiple applications of AMP-based NGS performed in a global CRO, discussing assay suitability and performance for multiple disease and mutation types


Sep
6
2016

PierianDX and ArcherDX Announce Partnership Benefiting NGS Clinical Labs

PierianDX will integrate Archer® targeted NGS testing pipelines into the PierianDX Clinical Genomicist Workspace™


Aug
24
2016

ArcherDX presents at IAP/ESP 2016 in Cologne, Germany

Join us at the IAP/ESP 2016 International Congress in Cologne, Germany on Sept 25-29, 2016. Combining revolutionary AMP™ chemistry with an easy workflow and intuitive software, Archer® unleashes the power of translational NGS to enable mutation detection.


Aug
17
2016

Archer announces Research Challenge Grant Winners

Archer awards 5 recipients up to 192 free reactions (24 kits with 8 reactions each) of an Archer Assay of their choosing and training from our expert Field Applications Specialists.


Aug
16
2016

ArcherDX NGS assays receive conditional approval by New York State

ArcherDX, the leader in next-generation sequencing (NGS)-based gene fusion detection products, announced today that two Archer® FusionPlex® NGS assays have received conditional approval from the New York State Department of Health for clinical use by Memorial Sloan Kettering Cancer Center (MSK).


Aug
12
2016

AGBT-Precision Health 2016

Join us at AGBT Precision Health Meeting in Scottsdale, Arizona on Sept 22-24, 2016 to see how combining Archer® NGS assays with GenomOncology clinical reporting software can enable your precision oncology research


Jul
19
2016

ArcherDX at the Cancer Genomics Consortium 2016

Thanks for joining us at the CGC Summer Meeting 2016 in Denver, Colorado in August. By combining revolutionary AMP™ chemistry with an easy workflow and intuitive software, Archer® is unleashing the power of translational NGS to enable mutation detection.


Jul
19
2016

Characterizing hematologic malignancies with ArcherDX blood cancer assays

This webinar will review multiple applications ArcherDX® FusionPlex® and VariantPlex™ blood cancer assays to address the significant clinical implications in the diagnosis and management of hematologic malignancies.


Jul
7
2016

ArcherDX at EACR24

Going to EACR24? Join ArcherDX for in-booth presentations on ArcherDX’s exciting FusionPlex products and bioinformatics analysis tools. Presentations will be hosted by ArcherDX in booth D470.


May
31
2016

ArcherDX to collaborate with Illumina on NGS-based in vitro diagnostics development

ArcherDX will lead development of diagnostic tests powered by Anchored Multiplex PCR (AMP™) enrichment chemistry that will run on the Illumina® MiSeq® sequencing instrument


May
20
2016

ArcherDX at ASCO 2016

Join us at the ASCO Annual Meeting 2016 in Chicago, Illinois from June 3-7, 2016. By combining revolutionary AMP™ chemistry with an easy workflow and intuitive software, Archer® is unleashing the power of translational NGS to enable mutation detection.


May
12
2016

Developing and validating an ALK, ROS1, RET RNA fusion reference standard for targeted NGS

This webinar will detail the need for accurate and consistent fusion reference standards and how Horizon Discovery and ArcherDX partnered to develop the Archer™ SureShot™ ALK, RET, ROS1 standards.


May
2
2016

European Human Genetics Conference 2016

Join us for the 2016 European Human Genetics Conference in Barcelona, Spain from May 21-24. By combining revolutionary AMP™ chemistry with an easy workflow and intuitive software, Archer is unleashing the power of translational NGS to enable mutation detection.


Apr
16
2016

Archer announces Research Challenge Grant

Archer will award 5 recipients up to 192 free reactions (24 kits with 8 reactions each) of an Archer Assay of their choosing and training from our expert Field Applications Specialists.


Apr
7
2016

New Archer Blood Cancer NGS Assays announced at AACR 2016

Join us for AACR 2016 in New Orleans, LA from April 16-20. By combining revolutionary AMP™ chemistry with an easy workflow and intuitive software, Archer is unleashing the power of translational NGS to enable mutation detection.


Apr
6
2016

Next Generation Sequencing Applications and Sample Prep Workflow Improvements

This webinar will detail the advantages of gene fusion detection via RNA-Seq methods and enhancements that can be gained through improvements in nucleic acid purification protocols.


Apr
1
2016

ArcherDX at the 13th International Congress of Human Genetics (ICHG)

Join us for the International Congress of Human Genetics in Kyoto, Japan from April 3-7, 2016. By combining revolutionary AMP™ chemistry with an easy workflow and intuitive software, Archer is unleashing the power of translational NGS to enable mutation detection.

Subscribe to stay in the loop







How to contact us

Address

2477 55th Street, Suite 202

Boulder, CO 80301

Phone

Phone: (877) 771 1093

Phone: (303) 357 9001

All content © 2017 ArcherDX, Inc.

For Research Use Only. Not for use in diagnostic procedures. For Research Use Only. Not for use in diagnostic procedures.